Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Curious about your investment portfolio? Discover what to include to ensure a balanced and profitable mix of assets.
23,656 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
Intuitive Surgical has faced a sharp stock pullback this year. This article breaks down the factors behind the move, ...
As volatility persists in 2026, savvy investors are exploring the tax advantages of placing Main Street Capital in a ...
Oracle stock drop today? sent shockwaves through the tech arena as investors weigh cloud strategy and AI momentum. Th...
As earnings season unfolds, Apogee faces a meaningful year ahead. This article breaks down Q1 signals, outlines a rea...
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
A $700,000 taxable account could generate roughly $19,000 in annual income via direct indexing, combining steady divi...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
GE Vernova's stock slide today highlights how AI data center growth and sector volatility interact with broader marke...